SCA revenue up 8%, Symbion revenue up 7.5%, Tenet stock up 8% & new AmSurg health system partnerships – 5 key notes on ASC companies
Surgical Care Affiliates reported $196.7 million in total net operating revenues, excluding revenues from centers in which the company does not hold a controlling interest, for the second quarter of 2014. This is an 8 percent increase from $196.7 million in the year prior.
Symbion reported $142.2 million in second quarter revenue, up 7.5 percent from $132.3 million in the second quarter of 2013.
Medical Facilities Corporation reported $74.4 million in revenue for the second quarter of 2014, up 0.9 percent from $73.7 million in the second quarter of 2013.
During the second quarter, AmSurg deconsolidated three surgery centers and contributed their controlling interests in the centers to create two joint ventures with two health systems.
Tenet Healthcare stock traded at $56.83 per share during the week of August 4 to 8, up 8.58 percent.
If you have a question, issue or note to suggest on an ASC management and development company please contact Carrie Pallardy at firstname.lastname@example.org or Laura Dyrda at email@example.com.
More articles on ASC issues:
How to handle managed care contracts prior to entering a hospital joint venture
4 recent ASC industry leadership moves
7 things for ASC leaders to know for Thursday
© Copyright ASC COMMUNICATIONS 2015. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
New From Becker's ASC Review
6 notes on primary care physicians' outlook on healthcare technologyRead Now
- Dr. Julie Servoss: A GI tech must-have
- GI society roundtable: Putting together the game plan for potential colonoscopy cuts
- 5 critical steps to developing an ASC risk management program
- Researchers reconstruct ancient virus to enhance gene therapy — 5 notes
- GI physician leader to know: Dr. Jacques Van Dam of USC's Keck School Medicine